Isoxazole - CAS 288-14-2
Catalog: |
BB019963 |
Product Name: |
Isoxazole |
CAS: |
288-14-2 |
Synonyms: |
1,2-oxazole |
Application: |
4-chloro-6-(4-(trifluoromethyl)piperidin-1-yl)pyrimidine (cas# 1491288-14-2) is a useful research chemical. |
IUPAC Name: | 1,2-oxazole |
Description: | Isoxazole can act as an acetylcholinesterase (AChE) inhibitor. |
Molecular Weight: | 69.06 |
Molecular Formula: | C3H3NO |
Canonical SMILES: | C1=CON=C1 |
InChI: | InChI=1S/C3H3NO/c1-2-4-5-3-1/h1-3H |
InChI Key: | CTAPFRYPJLPFDF-UHFFFAOYSA-N |
Boiling Point: | 95 °C |
Purity: | > 98 % |
Density: | 1.078 g/cm3 |
Appearance: | Clear light brown liquid |
MDL: | MFCD00003149 |
LogP: | 0.67460 |
Vapor Pressure: | 45.5 [mmHg] |
GHS Hazard Statement: | H225 (100%): Highly Flammable liquid and vapor [Danger Flammable liquids] |
Precautionary Statement: | P210, P233, P240, P241, P242, P243, P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P370+P378, P403+P235, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021198332-A1 | Condensation product for use in a method for the treatment of covid-19 | 20200401 |
WO-2020263703-A1 | Enhancement of nucleic acid polymerization by aromatic compounds | 20190626 |
CN-109456302-A | The preparation method of impurity in a kind of Metalaxyl-M | 20181220 |
WO-2020105660-A1 | Novel imidazole derivative | 20181121 |
KR-20210093884-A | Novel imidazole derivatives | 20181121 |
PMID | Publication Date | Title | Journal |
33016515 | 20201201 | Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus) | Veterinary dermatology |
32941854 | 20201101 | Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy | Toxicology and applied pharmacology |
32109490 | 20200601 | Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy | Pharmacology & therapeutics |
31940200 | 20200423 | Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis | Journal of medicinal chemistry |
32203695 | 20200401 | Use of afoxolaner for the treatment of lice (Goniodes pavonis) in different genera (Chrysolophus spp, Lophura spp, Phasianus spp, and Syrmaticus spp) and species of pheasants and West Mexican Chachalacas (Ortalis poliocephala) | Veterinary parasitology |
Complexity: | 30.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 69.021463719 |
Formal Charge: | 0 |
Heavy Atom Count: | 5 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 69.021463719 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 26 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Isoxazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS